Chikungunya IgM test is a blood test that helps to detect the presence of specific antibodies immunoglobulin M (IgM) produced by the body in response to the Chikungunya virus. It is used to screen a recent infection and helps in timely intervention. Chikungunya is a mosquito-borne infection that can cause an abrupt onset of fever, often accompanied by joint pain and other symptoms such as muscle pain, headache, nausea, fatigue, and rash. When an individual is infected with the Chikungunya virus, the immune system produces IgM antibodies as a response. The Chikungunya IgM test examines the presence of these antibodies in the bloodstream, helping to confirm recent exposure to the virus. As Chikungunya shares symptoms with other mosquito-borne diseases like dengue, malaria, and Zika, accurate diagnosis is challenging. The Chikungunya IgM test is crucial for confirming the virus’s presence, ensuring an accurate diagnosis, and guiding appropriate management. A Chikungunya IgM test is most effective when conducted during the initial phase of infection, i.e., within the first week of symptoms onset as it provides a crucial time window to identify the presence of Chikungunya IgM antibodies in the blood. This test is useful in regions where Chikungunya is endemic or during periods of increased mosquito activity.

Chikungunya Virus Antibody IgM: Measures the presence of Immunoglobulin M (IgM) antibodies in the blood, specifically targeting the Chikungunya virus. These antibodies are produced in response to a recent Chikungunya infection, helping diagnose the active phase of the disease.

Test price for other cities